Printer-friendly format

The BioVentures program at UAMS has 12 companies that are considered "clients." Two of those companies responded to a questionnaire by the Medical News of Arkansas. The information for those two — InterveXion and BALM Innovations — can be found on Page 5.

The other 10 companies are, in some cases, not much more than an idea. But in other cases, they are waiting for the right venture capitalist to come along and move them into the "graduate" category.
What follows are those 10 companies and a brief description of what they do.

Seer Pharmaceuticals, LLC
What they do: This company offers a novel treatment for specific food allergy disorders and is also working on a potential treatment for cystic fibrosis.

Stage 1 Diagnostics, LLC
What they do: Stage I Diagnostics' mission is to develop and produce a panel-based system for the early detection of cancer and especially for the early detection of ovarian cancer. Another product is in the works for prostate cancer.

Type IV Technologies, LLC
What they do: Type IV and a major formulation company partner are developing a new therapy for warts, using an FDA-approved skin test antigen. Type IV was a company selected to present its business plan to the Arkansas Venture Capital Forum.

DCV Technologies, Inc.
What they do: DCV Technologies is dedicated to the development of therapeutic vaccines for the treatment of cancer, based on core technologies developed at UAMS. The initial focus is on the development of a treatment of gynecological malignancies and prostate cancer. A vaccine for the treatment of cervical cancer received FDA approval in March 2001 for combined phase I/phase II clinical trials.

NanoBlade, LLC
What they do: NanoBlade is developing an automated Micro Fresh Tissue Sectioning and 3D tissue reconstruction device that has primary applications in both surgical and clinical pathology examinations. NanoBlade was a company selected to present its business plan to the Arkansas Venture Capital Forum.

IntraTherm, LLC
What they do: IntraTherm is producing a conductive interstitial thermal therapy device designed to eliminate malignant and benign tumors/lesions with very precise heat radiation. The company has partnered with a device company
in Chicago.

IRV, Inc.
What they do: IRV offers an Infrared Veniscope for use in both clinic and hospital settings, as well as multiple Department of Defense applications. This device is an infrared enhanced virtual reality viewer, designed to be worn, like goggles, over the healthcare provider's eyes in order to clearly see the veins below the surface of the skin.

Physicians' Assessment Systems Services (PASS)
What they do: The company, founded in the UAMS Department of Psychiatry, will offer access to therapeutic results databases. The service is providing physicians access to a wide range of therapy results data, largely in the area of depression, enabling more accurate prescriptions and doses.

XenoCept, Inc.
What they do: This company is based on recent discoveries in xenotransplantation, the transplantation of organs from one species to another.

Ortho Unique, LLC
What they do: The company's core technology is an orthopedic device that greatly improves the hip replacement procedure. The device consists of a plunger and bowl mounted in a loading frame that is used to create an acetabular cup composite, made of compressed allograft bone and interdigitated cement, for use in patients with acetabular defects.

Tags:

None

Do you know someone else who would like to see this?
Your Email:
Their Email:
Comment:	(Will be included with e-mail)
Secret Code	In the box below, enter the Secret Code exactly as it appears above *